Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Finasteride can treat prostatic haematuria, but its use is controversial.

Grape seed extract may safely and effectively help prevent lung cancer.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Clascoterone may be a promising treatment for hair loss.

Finasteride helps hair growth but may cause sexual side effects and depression.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Mutations in the P2RY5 gene cause hereditary woolly hair.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Stem cells are crucial for skin repair and new treatments for chronic wounds.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.